Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting.
- DOI
- 10.21037/atm-20-7163
- Published
- 2021 Apr
- Container
- Annals of translational medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/atm-20-7163,
title = {Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting.},
author = {Huang J and Zhang L and Wu S and Lu J and Li F and Cheng Y and Zhang Q and Li G and Yu H and Le Z and He X and Ding Y and Candotti D and Xie X and Zhang J},
year = {2021},
journal = {Annals of translational medicine},
doi = {10.21037/atm-20-7163},
url = {https://doi.org/10.21037/atm-20-7163}
}RIS
TY - JOUR TI - Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting. AU - Huang J AU - Zhang L AU - Wu S AU - Lu J AU - Li F AU - Cheng Y AU - Zhang Q AU - Li G AU - Yu H AU - Le Z AU - He X AU - Ding Y AU - Candotti D AU - Xie X AU - Zhang J PY - 2021 JO - Annals of translational medicine DO - 10.21037/atm-20-7163 UR - https://doi.org/10.21037/atm-20-7163 ER -
APA
J, H., L, Z., S, W., J, L., F, L., Y, C., Q, Z., G, L., H, Y., Z, L., X, H., Y, D., D, C., X, X., & J, Z. (2021). Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting.. Annals of translational medicine. https://doi.org/10.21037/atm-20-7163
Source records
- pubmed · retrieved 2026-09-26T21:10:00.722Z